methylnitrosourea has been researched along with Alopecia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MH; Chen, YL; Chiu, HW; Fang, WH; Hung, CM; Wang, YJ; Wu, MD; Wu, MJ; Yuan, GF | 1 |
Kiyozuka, Y; Nambu, H; Shikata, N; Tsubura, A; Yamamoto, D; Yang, J; Yoshizawa, K | 1 |
Kolarić, K | 1 |
3 other study(ies) available for methylnitrosourea and Alopecia
Article | Year |
---|---|
Preventive effects of Monascus on androgen-related diseases: androgenetic alopecia, benign prostatic hyperplasia, and prostate cancer.
Topics: Administration, Oral; Aging; Alopecia; Animals; Dihydrotestosterone; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Monascus; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone | 2013 |
Time-specific occurrence of alopecia in neonatal C57BL mice treated with N-methyl-N-nitrosourea and the therapeutic efficacy of tacrolimus hydrate.
Topics: Alkylating Agents; Alopecia; Animals; Apoptosis; bcl-2-Associated X Protein; Female; Immunosuppressive Agents; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tacrolimus; Time Factors; Up-Regulation | 2000 |
Combination chemotherapy with 1-methyl-1-nitrosourea (MNU) and cyclophosphamide in solid tumors.
Topics: Adult; Alopecia; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukopenia; Male; Melanoma; Methylnitrosourea; Middle Aged; Nausea; Nitrosourea Compounds | 1977 |